EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions

Alexandra Paolino iD, Helen Alexander iD, Conor Broderick iD, Carsten Flohr iD

Clinical & Experimental Allergy · 2023-05 · 53 (5) · 495-510

DOI: 10.1111/cea.14301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 22.03.2023. Verfasst von Alexandra Paolino und 3 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition with an unpredictable clinical course, associated with a significant impact on quality of life. The pathophysiology of AD involves a complex interplay between impaired skin barrier function, immune dysregulation, genetic susceptibility and environmental factors. Advances in understanding of the immunological mechanisms that underpin AD have heralded the recognition of multiple novel therapeutic targets to bolster the systemic treatment armamentarium for patients with severe AD. This review examines current and future directions of non‐biologic systemic treatments for AD, with a focus on their mechanism of action, efficacy and safety, and the key considerations to help inform treatment decisions. We summarize new developments in small molecule systemic therapies which have the potential to further advance our management of AD in this new era of precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansQuality of LifeAdministration, CutaneousPrecision Medicine

Stichwörter der Autor:innen

Janus kinase inhibitorsatopic dermatitissmall molecule inhibitorssystemic treatment

Autor:innen und Institutionen

  • St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

ORCID-Profile: Alexandra Paolino, Helen Alexander, Conor Broderick, Carsten Flohr

Zitieren

APA

Paolino, A., Alexander, H., Broderick, C., & Flohr, C. (2023). Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions. Clinical & Experimental Allergy, 53(5), 495-510. https://doi.org/10.1111/cea.14301

Vancouver

Paolino A, Alexander H, Broderick C, Flohr C. Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions. Clinical & Experimental Allergy. 2023;53(5):495-510. doi:10.1111/cea.14301

BibTeX
@article{Paolino2023,
  author = {Paolino, Alexandra and Alexander, Helen and Broderick, Conor and Flohr, Carsten},
  title = {Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions},
  journal = {Clinical & Experimental Allergy},
  year = {2023},
  volume = {53},
  number = {5},
  pages = {495--510},
  doi = {10.1111/cea.14301}
}
Kostenlos starten →